Cerenome (CNSY) Revenue Growth (1y) (2012 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Revenue Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 12.45% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 16.73% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 59.71% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 2.11% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 29.63% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 66.86% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 16.50% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 296.11% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -70.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -70.43% |
| Mar 31, 2026 | -2.93% |
| Dec 31, 2025 | -3.19% |
| Sep 30, 2025 | -4.05% |
| Jun 30, 2025 | 8.68% |
| Mar 31, 2025 | -36.85% |
| Dec 31, 2024 | 7.54% |
| Sep 30, 2024 | -66.91% |
| Jun 30, 2024 | -32.68% |
| Mar 31, 2024 | 231.42% |
| Dec 31, 2023 | 769.54% |
| Sep 30, 2023 | 5,927.40% |
| Mar 31, 2019 | -3.83% |
| Dec 31, 2018 | 114.80% |
| Sep 30, 2018 | 83.73% |
| Jun 30, 2018 | -31.89% |
| Mar 31, 2018 | 23.69% |
| Dec 31, 2017 | -54.84% |
| Sep 30, 2017 | -36.11% |
| Jun 30, 2017 | -13.94% |